Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression

Cancer Research

Volumn 59, Issue 14, 1999, Pages 3333-3339

  Ji, Lin ^a   Fang, Bingliang ^a   Yen, Nancy ^a   Fong, Kwun ^b   Minna, John D ^b   Roth, Jack A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTIDINE; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENESIS; CARCINOGENICITY; CELL CULTURE; CELL GROWTH; CELL KINETICS; CELL PROLIFERATION; CYTOGENETICS; EXON; GENE DELETION; GENE OVEREXPRESSION; GENE REARRANGEMENT; GENE STRUCTURE; HEAD AND NECK CANCER; LUNG CANCER; NONHUMAN; NUDE MOUSE; PLAQUE FORMING CELL; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ACID ANHYDRIDE HYDROLASES; ADENOVIRIDAE; ANIMALS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; GENES, TUMOR SUPPRESSOR; GENETIC VECTORS; HEAD AND NECK NEOPLASMS; HUMANS; INJECTIONS, INTRALESIONAL; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; PROTEIN BIOSYNTHESIS; PROTEINS; TUMOR CELLS, CULTURED;

EID: 0033565920     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Ohta, M., Inoue, H., Cotticelli, M. G., Kastury, K., Baffa, R., Palazzo, J., Siprashvili, Z., Mori, M., McCue, P., Druck, T., Croce, C. M., and Huebner, K. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell, 84: 587-597, 1996.
2. Druck, T., Hadaczek, P., Fu, T. B., Ohta, M., Siprashvili, Z., Baffa, R., Negrini, M., Kastury, K., Veronese, M. L., Rosen, D., Rothstein, J., McCue, P., Cotticelli, M. G., Inoue, H., Croce, C. M., and Huebner, K. Structure and expression of the human FHIT gene in normal and tumor cells. Cancer Res., 57: 504-512, 1997.
3. Greensnan, D. L., Connolly, D. C., Wu, R., Lei, R. Y., Vogelstein, J. T., Kim, Y. T., Mok, J. E., Munoz, N., Bosch, F. X., Shah, K., and Cho, K. R. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors. Cancer Res., 57: 4692-4698, 1997.
4. Huebner, K., Hadaczek, P., Siprashvili, Z., Druck, T., and Croce, C. M. The FHIT gene, a multiple tumor suppressor gene encompassing the carcinogen sensitive chromosome fragile site, FRA3B (Review). Biochim. Biophys. Acta, 1332: M65-M70, 1997.
5. Lebeau, M. M., Drabkin, H., Glover, T. W., Gemmill, R., Rassool, F. V., Mckeithan, T. W., and Smith, D. I. An FHIT tumor suppressor gene. Genes Chromosomes Cancer, 21: 281-289, 1998.
6. Mao, L. Tumor suppressor genes: does FHIT fit? (Editorial; Comment). J. Natl. Cancer Inst., 90: 412-414, 1998.
7. Sozzi, G., Veronese, M. L., Negrini, M., Baffa, R., Cotticelli, M. G., Inoue, H., Tornielli, S., Pilotti, S., DeGregorio, L., Pastorino, U., Pierotti, M. A., Ohta, M., Huebner, K., and Croce, C. M. The FHIT gene 3p14.2 is abnormal in lung cancer. Cell, 85: 17-26, 1997.
8. Sozzi, G., Sard, L., DeGregorio, L., Marchetti, A., Musso, K., Buttitta, F., Tornielli, S., Pellegrini, S., Veronese, M. L., Manenti, G., Incarbone, M., Chella, A., Angeletti, C. A., Pastorino, U., Huebner, K., Bevilaqua, G., Pilotti, S., Croce, C. M., and Pierotti, M. A. Association between cigarette smoking and FHIT gene alterations in lung cancer. Cancer Res., 57: 2121-2123, 1997.
9. Fong, K. M., Biesterveld, E. J., Virmani, A., Wistuba, I., Sekido, Y., Bader, S. A., Ahmadian, M., Ong, S. T., Rassool, F. V., Zimmerman, P. V., Giaccone, G., Gazdar, A. F., and Minna, J. D. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. Cancer Res., 57: 2256-2267, 1997.
10. Virgilio, L., Shuster, M., Gollin, S. M., Veronese, M. L., Ohta, M., Huebner, K., and Croce, C. M. FHIT gene alterations in head and neck squamous cell carcinomas. Proc. Natl. Acad. Sci. USA, 93: 9770-9775, 1996.
11. Bugert, P., Wilhelm, M., and Kovacs, G. FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas. Genes Chromosomes Cancer, 20: 9-15, 1997.
12. van den Berg, A., Draaijers, T. G., Kok, K., Timmer, T., Van Der Veen, A. Y., Veldhuis, P. M., de Leij, L., Gerhartz, C. D., Naylor, S. L., Smith, D. I., and Buys, C. H. Normal FHIT transcripts in renal cell cancer-and lung cancer-derived cell lines, including a cell line with a homozygous deletion in the FRA3B region. Genes Chromosomes Cancer, 19: 220-227, 1997.
13. Michael, D., Beer, D. G., Wilke, C. W., Miller, D. E., and Glover, T. W. Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas. Oncogene, 15: 1653-1659, 1997.
14. Siprashvili, Z., Sozzi, G., Barnes, L. D., McCue, P., Robinson, A. K., Eryomin, V., Sard, L., Tagliabue, E., Greco, A., Fusetti, L., Schwartz, G., Pierotti, M. A., Croce, C. M., and Huebner, K. Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc. Natl. Acad. Sci. USA., 94: 13771-13776, 1997.
15. Otterson, G. A., Xiao, G. H., Geradts, J., Jin, F., Chen, W. D., Niklinska, W., Kaye, F. J., and Yeung, R. S. Protein expression and functional analysis of the FHIT gene in human tumor cells. J. Natl. Cancer Inst., 90: 426-432, 1998.
16. Fang, B., Koch, P. E., and Roth, J. A. Diminishing adenovirus gene expression and viral replication by promoter replacement. J. Virol., 71: 4798-4803, 1997.
17. Ji, L., Bouvet, M., Price, R., Roth, J. A., and Fang, B. Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement. Gene Ther., 6: 393-402, 1999.
18. Mao, L., Fan, Y. H., Lotan, R., and Hong, W. K. Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines. Cancer Res., 56: 5128-5131, 1996.
19. Sozzi, G., Tornielli, S., Tagliabue, E., Sard, L., Pezzella, F., Pastorino, U., Minoletti, F., Pilotti, S., Ratcliffe, C. Veronese, M. L., Goldstraw, P., Huebner, K., Croce, C. M., and Pierotti, M. A. Absence of Fhit protein in primary lung tumors and cell lines with FHIT gene abnormalities. Cancer Res., 57: 5207-5212, 1997.
20. Hadaczek, P., Siprashvili, Z., Markiewski, M., Domagala, W., Druck, T., McCue, P. A., Pekarsky, Y., Ohta, M., Huebner, K., and Lubinski, J. Absence or reduction of Fhit expression in most clear cell renal carcinomas. Cancer Res., 58: 2946-2951, 1998.
21. Mao, L., Lee, J. S., Kurie, J. M., Fan, Y. H., Lippman, S. M., Lee, J. J., Ro, J. Y., Broxson, A., Yu, R., Morice, R. C., Kemp, B. L., Khuri, F. R., Walsh, G. L., Hittelman, W. N., and Hong, W. K. Clonal genetic alterations in the lungs of current and former smokers. J. Natl. Cancer Inst., 89: 857-862, 1997.
22. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell, 88: 323-331, 1997.
23. Naik, P., Karrim, J., and Hanahan, D. The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors. Genes Dev., 10: 2105-2116, 1996.
24. Roth, J. A., and Cristiano, R. J. Gene therapy for cancer: What have we done and where are we going? (Review). J. Natl. Cancer Inst., 89: 21-39, 1997.
25. Clayman, G. L., Liu, T. J., Overholt, S. M., Mobley, S. R., Wang, M., Janot, F., and Goepfert, H. Gene therapy for head and neck cancer: comparing the tumor suppressor gene p53 and a cell cycle regulator WAF1/CIP1 (P21). Arch. Otolaryngol. Head Neck Surg., 122: 489-493, 1996.
26. Brenner, C., Garrison, P., Gilmour, J., Peisach, D., Ringe, D., Petsko, G. A., and Lowenstein, J. M. Crystal structures of HINT demonstrate that histidine triad proteins are GalT-related nucleotide-binding proteins. Nat. Struct. Biol., 4: 231-238, 1997.
27. Sherr, C. J. Cancer cell cycles (Review). Science (Washington DC), 274: 1672-1677, 1996.
28. Pace, H. C., Garrison, P. N., Robinson, A. K., Barnes, L. D., Draganescu, A., Rosler, A., Blackburn, G. M., Siprashvili, Z., Croce, C. M., Huebner, K., and Brenner, C. Genetic, biochemical, and cristallographic characterization of Phit-substrate complexes as the active signaling form of Fhit. Proc. Natl. Acad. Sci. USA, 95: 5484-5489, 1998.
29. Lima, C. D., Klein, M. G., and Hendrickson, W. A. Structure-based analysis of catalysis and substrate definition in the HIT protein family. Science (Washington DC), 278: 286-290, 1997.
30. Sozzi, G., Huebner, K., and Croce, C. M. FHIT in human cancer. Adv. Cancer Res., 74: 141-166, 1998.
31. Green, D. R., and Reed, J. C. Mitochondria and apoptosis (Review). Science (Washington DC), 281: 1309-1312, 1998.
32. Kisselev, L. L., Justesen, J., Wolfson, A. D., and Frolova, L. Y. Diadenosine oligophosphates (Ap(n)A), a novel class of signalling molecules? (Review). FEBS Lett., 427: 157-163, 1998.
33. Vartanian, A., Narovlyansky, A., Amchenkova, A., Turpaev, K., and Kisselev, L. Interferons induce accumulation of diadenosine triphosphate (Ap3A) in human cultured cells. FEBS Lett., 381: 32-34, 1996.
34. Vartanian, A., Prudovsky, I., Suzuki, H., Dal Pra, I., and Kisselev, L. Opposite effects of cell differentiation and apoptosis on Ap3A/Ap4A ratio in human cell cultures. FEBS Lett., 415: 160-162, 1997.
35. Wang, X. W., and Harris, C. C. TP53 tumor suppressor gene: clues to molecular carcinogenesis and cancer therapy (Review). Cancer Surv., 28: 169-196, 1996.
36. Evan, G., and Littlewood, T. A matter of life and cell death. Science (Washington DC), 281: 1317-1322, 1998.